The global market for T-Cell Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for T-Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for T-Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for T-Cell Therapy in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of T-Cell Therapy include Gilead Sciences, Inc., Sorrento Therapeutics, Fate Therapeutics Inc., Novartis International AG, AbbVie Inc., Adaptimmune Therapeutics PLC, Bluebird Bio, TCR2 Therapeutics, Inc., Pfizer Inc., DiaCarta, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for T-Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding T-Cell Therapy.

The T-Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global T-Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the T-Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of T-Cell Therapy Market Report

Report Metric	Details
Report Name	T-Cell Therapy Market
Segment by Type	CAR T Cell Therapy TCR Therapy TIL Therapy
Segment by Application	Hospitals Clinics & Ambulatory Centers Cancer Research Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Gilead Sciences, Inc., Sorrento Therapeutics, Fate Therapeutics Inc., Novartis International AG, AbbVie Inc., Adaptimmune Therapeutics PLC, Bluebird Bio, TCR2 Therapeutics, Inc., Pfizer Inc., DiaCarta, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of T-Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the T-Cell Therapy Market report?

Ans: The main players in the T-Cell Therapy Market are Gilead Sciences, Inc., Sorrento Therapeutics, Fate Therapeutics Inc., Novartis International AG, AbbVie Inc., Adaptimmune Therapeutics PLC, Bluebird Bio, TCR2 Therapeutics, Inc., Pfizer Inc., DiaCarta, Inc.

What are the Application segmentation covered in the T-Cell Therapy Market report?

Ans: The Applications covered in the T-Cell Therapy Market report are Hospitals, Clinics & Ambulatory Centers, Cancer Research Institutes, Others

What are the Type segmentation covered in the T-Cell Therapy Market report?

Ans: The Types covered in the T-Cell Therapy Market report are CAR T Cell Therapy, TCR Therapy, TIL Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global T-Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 CAR T Cell Therapy

1.2.3 TCR Therapy

1.2.4 TIL Therapy

1.3 Market by Application

1.3.1 Global T-Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics & Ambulatory Centers

1.3.4 Cancer Research Institutes

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global T-Cell Therapy Market Perspective (2020-2031)

2.2 Global T-Cell Therapy Growth Trends by Region

2.2.1 Global T-Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 T-Cell Therapy Historic Market Size by Region (2020-2025)

2.2.3 T-Cell Therapy Forecasted Market Size by Region (2026-2031)

2.3 T-Cell Therapy Market Dynamics

2.3.1 T-Cell Therapy Industry Trends

2.3.2 T-Cell Therapy Market Drivers

2.3.3 T-Cell Therapy Market Challenges

2.3.4 T-Cell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top T-Cell Therapy Players by Revenue

3.1.1 Global Top T-Cell Therapy Players by Revenue (2020-2025)

3.1.2 Global T-Cell Therapy Revenue Market Share by Players (2020-2025)

3.2 Global T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by T-Cell Therapy Revenue

3.4 Global T-Cell Therapy Market Concentration Ratio

3.4.1 Global T-Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by T-Cell Therapy Revenue in 2024

3.5 Global Key Players of T-Cell Therapy Head office and Area Served

3.6 Global Key Players of T-Cell Therapy, Product and Application

3.7 Global Key Players of T-Cell Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 T-Cell Therapy Breakdown Data by Type

4.1 Global T-Cell Therapy Historic Market Size by Type (2020-2025)

4.2 Global T-Cell Therapy Forecasted Market Size by Type (2026-2031)

5 T-Cell Therapy Breakdown Data by Application

5.1 Global T-Cell Therapy Historic Market Size by Application (2020-2025)

5.2 Global T-Cell Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America T-Cell Therapy Market Size (2020-2031)

6.2 North America T-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America T-Cell Therapy Market Size by Country (2020-2025)

6.4 North America T-Cell Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe T-Cell Therapy Market Size (2020-2031)

7.2 Europe T-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe T-Cell Therapy Market Size by Country (2020-2025)

7.4 Europe T-Cell Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific T-Cell Therapy Market Size (2020-2031)

8.2 Asia-Pacific T-Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific T-Cell Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific T-Cell Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America T-Cell Therapy Market Size (2020-2031)

9.2 Latin America T-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America T-Cell Therapy Market Size by Country (2020-2025)

9.4 Latin America T-Cell Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa T-Cell Therapy Market Size (2020-2031)

10.2 Middle East & Africa T-Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa T-Cell Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa T-Cell Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Gilead Sciences, Inc.

11.1.1 Gilead Sciences, Inc. Company Details

11.1.2 Gilead Sciences, Inc. Business Overview

11.1.3 Gilead Sciences, Inc. T-Cell Therapy Introduction

11.1.4 Gilead Sciences, Inc. Revenue in T-Cell Therapy Business (2020-2025)

11.1.5 Gilead Sciences, Inc. Recent Development

11.2 Sorrento Therapeutics

11.2.1 Sorrento Therapeutics Company Details

11.2.2 Sorrento Therapeutics Business Overview

11.2.3 Sorrento Therapeutics T-Cell Therapy Introduction

11.2.4 Sorrento Therapeutics Revenue in T-Cell Therapy Business (2020-2025)

11.2.5 Sorrento Therapeutics Recent Development

11.3 Fate Therapeutics Inc.

11.3.1 Fate Therapeutics Inc. Company Details

11.3.2 Fate Therapeutics Inc. Business Overview

11.3.3 Fate Therapeutics Inc. T-Cell Therapy Introduction

11.3.4 Fate Therapeutics Inc. Revenue in T-Cell Therapy Business (2020-2025)

11.3.5 Fate Therapeutics Inc. Recent Development

11.4 Novartis International AG

11.4.1 Novartis International AG Company Details

11.4.2 Novartis International AG Business Overview

11.4.3 Novartis International AG T-Cell Therapy Introduction

11.4.4 Novartis International AG Revenue in T-Cell Therapy Business (2020-2025)

11.4.5 Novartis International AG Recent Development

11.5 AbbVie Inc.

11.5.1 AbbVie Inc. Company Details

11.5.2 AbbVie Inc. Business Overview

11.5.3 AbbVie Inc. T-Cell Therapy Introduction

11.5.4 AbbVie Inc. Revenue in T-Cell Therapy Business (2020-2025)

11.5.5 AbbVie Inc. Recent Development

11.6 Adaptimmune Therapeutics PLC

11.6.1 Adaptimmune Therapeutics PLC Company Details

11.6.2 Adaptimmune Therapeutics PLC Business Overview

11.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Introduction

11.6.4 Adaptimmune Therapeutics PLC Revenue in T-Cell Therapy Business (2020-2025)

11.6.5 Adaptimmune Therapeutics PLC Recent Development

11.7 Bluebird Bio

11.7.1 Bluebird Bio Company Details

11.7.2 Bluebird Bio Business Overview

11.7.3 Bluebird Bio T-Cell Therapy Introduction

11.7.4 Bluebird Bio Revenue in T-Cell Therapy Business (2020-2025)

11.7.5 Bluebird Bio Recent Development

11.8 TCR2 Therapeutics, Inc.

11.8.1 TCR2 Therapeutics, Inc. Company Details

11.8.2 TCR2 Therapeutics, Inc. Business Overview

11.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Introduction

11.8.4 TCR2 Therapeutics, Inc. Revenue in T-Cell Therapy Business (2020-2025)

11.8.5 TCR2 Therapeutics, Inc. Recent Development

11.9 Pfizer Inc.

11.9.1 Pfizer Inc. Company Details

11.9.2 Pfizer Inc. Business Overview

11.9.3 Pfizer Inc. T-Cell Therapy Introduction

11.9.4 Pfizer Inc. Revenue in T-Cell Therapy Business (2020-2025)

11.9.5 Pfizer Inc. Recent Development

11.10 DiaCarta, Inc.

11.10.1 DiaCarta, Inc. Company Details

11.10.2 DiaCarta, Inc. Business Overview

11.10.3 DiaCarta, Inc. T-Cell Therapy Introduction

11.10.4 DiaCarta, Inc. Revenue in T-Cell Therapy Business (2020-2025)

11.10.5 DiaCarta, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sorrento Therapeutics

Fate Therapeutics, Inc

Novartis International AG

AbbVie

Adaptimmune Therapeutics Plc

Bluebird bio

TCR2 Therapeutics, Inc.

Pfizer Inc

DiaCarta, Inc.

Gilead Sciences Inc

List of Tables

Table 1. Global T-Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of CAR T Cell Therapy

Table 3. Key Players of TCR Therapy

Table 4. Key Players of TIL Therapy

Table 5. Global T-Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global T-Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global T-Cell Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global T-Cell Therapy Market Share by Region (2020-2025)

Table 9. Global T-Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global T-Cell Therapy Market Share by Region (2026-2031)

Table 11. T-Cell Therapy Market Trends

Table 12. T-Cell Therapy Market Drivers

Table 13. T-Cell Therapy Market Challenges

Table 14. T-Cell Therapy Market Restraints

Table 15. Global T-Cell Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global T-Cell Therapy Market Share by Players (2020-2025)

Table 17. Global Top T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Therapy as of 2024)

Table 18. Ranking of Global Top T-Cell Therapy Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by T-Cell Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of T-Cell Therapy, Headquarters and Area Served

Table 21. Global Key Players of T-Cell Therapy, Product and Application

Table 22. Global Key Players of T-Cell Therapy, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global T-Cell Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global T-Cell Therapy Revenue Market Share by Type (2020-2025)

Table 26. Global T-Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global T-Cell Therapy Revenue Market Share by Type (2026-2031)

Table 28. Global T-Cell Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global T-Cell Therapy Revenue Market Share by Application (2020-2025)

Table 30. Global T-Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global T-Cell Therapy Revenue Market Share by Application (2026-2031)

Table 32. North America T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America T-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America T-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe T-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe T-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific T-Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific T-Cell Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific T-Cell Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America T-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America T-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa T-Cell Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa T-Cell Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 47. Gilead Sciences, Inc. Company Details

Table 48. Gilead Sciences, Inc. Business Overview

Table 49. Gilead Sciences, Inc. T-Cell Therapy Product

Table 50. Gilead Sciences, Inc. Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)

Table 51. Gilead Sciences, Inc. Recent Development

Table 52. Sorrento Therapeutics Company Details

Table 53. Sorrento Therapeutics Business Overview

Table 54. Sorrento Therapeutics T-Cell Therapy Product

Table 55. Sorrento Therapeutics Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)

Table 56. Sorrento Therapeutics Recent Development

Table 57. Fate Therapeutics Inc. Company Details

Table 58. Fate Therapeutics Inc. Business Overview

Table 59. Fate Therapeutics Inc. T-Cell Therapy Product

Table 60. Fate Therapeutics Inc. Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)

Table 61. Fate Therapeutics Inc. Recent Development

Table 62. Novartis International AG Company Details

Table 63. Novartis International AG Business Overview

Table 64. Novartis International AG T-Cell Therapy Product

Table 65. Novartis International AG Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)

Table 66. Novartis International AG Recent Development

Table 67. AbbVie Inc. Company Details

Table 68. AbbVie Inc. Business Overview

Table 69. AbbVie Inc. T-Cell Therapy Product

Table 70. AbbVie Inc. Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)

Table 71. AbbVie Inc. Recent Development

Table 72. Adaptimmune Therapeutics PLC Company Details

Table 73. Adaptimmune Therapeutics PLC Business Overview

Table 74. Adaptimmune Therapeutics PLC T-Cell Therapy Product

Table 75. Adaptimmune Therapeutics PLC Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)

Table 76. Adaptimmune Therapeutics PLC Recent Development

Table 77. Bluebird Bio Company Details

Table 78. Bluebird Bio Business Overview

Table 79. Bluebird Bio T-Cell Therapy Product

Table 80. Bluebird Bio Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)

Table 81. Bluebird Bio Recent Development

Table 82. TCR2 Therapeutics, Inc. Company Details

Table 83. TCR2 Therapeutics, Inc. Business Overview

Table 84. TCR2 Therapeutics, Inc. T-Cell Therapy Product

Table 85. TCR2 Therapeutics, Inc. Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)

Table 86. TCR2 Therapeutics, Inc. Recent Development

Table 87. Pfizer Inc. Company Details

Table 88. Pfizer Inc. Business Overview

Table 89. Pfizer Inc. T-Cell Therapy Product

Table 90. Pfizer Inc. Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)

Table 91. Pfizer Inc. Recent Development

Table 92. DiaCarta, Inc. Company Details

Table 93. DiaCarta, Inc. Business Overview

Table 94. DiaCarta, Inc. T-Cell Therapy Product

Table 95. DiaCarta, Inc. Revenue in T-Cell Therapy Business (2020-2025) & (US$ Million)

Table 96. DiaCarta, Inc. Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. T-Cell Therapy Picture

Figure 2. Global T-Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global T-Cell Therapy Market Share by Type: 2024 VS 2031

Figure 4. CAR T Cell Therapy Features

Figure 5. TCR Therapy Features

Figure 6. TIL Therapy Features

Figure 7. Global T-Cell Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global T-Cell Therapy Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Clinics & Ambulatory Centers Case Studies

Figure 11. Cancer Research Institutes Case Studies

Figure 12. Others Case Studies

Figure 13. T-Cell Therapy Report Years Considered

Figure 14. Global T-Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global T-Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global T-Cell Therapy Market Share by Region: 2024 VS 2031

Figure 17. Global T-Cell Therapy Market Share by Players in 2024

Figure 18. Global Top T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Therapy as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by T-Cell Therapy Revenue in 2024

Figure 20. North America T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America T-Cell Therapy Market Share by Country (2020-2031)

Figure 22. United States T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe T-Cell Therapy Market Share by Country (2020-2031)

Figure 26. Germany T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific T-Cell Therapy Market Share by Region (2020-2031)

Figure 34. China T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America T-Cell Therapy Market Share by Country (2020-2031)

Figure 42. Mexico T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa T-Cell Therapy Market Share by Country (2020-2031)

Figure 46. Turkey T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE T-Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Gilead Sciences, Inc. Revenue Growth Rate in T-Cell Therapy Business (2020-2025)

Figure 50. Sorrento Therapeutics Revenue Growth Rate in T-Cell Therapy Business (2020-2025)

Figure 51. Fate Therapeutics Inc. Revenue Growth Rate in T-Cell Therapy Business (2020-2025)

Figure 52. Novartis International AG Revenue Growth Rate in T-Cell Therapy Business (2020-2025)

Figure 53. AbbVie Inc. Revenue Growth Rate in T-Cell Therapy Business (2020-2025)

Figure 54. Adaptimmune Therapeutics PLC Revenue Growth Rate in T-Cell Therapy Business (2020-2025)

Figure 55. Bluebird Bio Revenue Growth Rate in T-Cell Therapy Business (2020-2025)

Figure 56. TCR2 Therapeutics, Inc. Revenue Growth Rate in T-Cell Therapy Business (2020-2025)

Figure 57. Pfizer Inc. Revenue Growth Rate in T-Cell Therapy Business (2020-2025)

Figure 58. DiaCarta, Inc. Revenue Growth Rate in T-Cell Therapy Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions